TAKEDA PHARMACEUTIC-SP ADR (TAK)

US8740602052 - ADR

13.22  -0.09 (-0.68%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2024
(2024-3-31)
2023
(2023-3-31)
2022
(2022-3-31)
2021
(2021-3-31)
2020
(2020-3-31)
Revenue
4263.76B4027.48B3569.01B3197.81B3291.19B
Minority Interest Expense
-130.00M-21.00M-107.00M-166.00M-49.00M
Cost Of Goods
1426.68B1244.07B1106.85B994.31B1089.76B
Gross Profit
2837.08B2783.41B2462.16B2203.50B2201.42B
Operating Expenses
2623.01B2232.51B1916.67B1867.78B1914.92B
Research and Development
729.92B633.33B526.09B455.83B492.38B
Selling, General, and Administrative Expenses
1053.82B997.31B886.36B875.66B964.74B
Operating Income
214.07B550.89B545.49B335.72B286.50B
Interest Income/Expense
-161.28B-158.20B-142.63B-234.72B-158.21B
Other Income/Expense
N/AN/A1.00MN/AN/A
Non Recurring Items
N/A-17.60B-100.29B265.23B-189.04B
Income Before Taxes
52.79B375.09B302.57B366.24B-60.75B
Income Tax
-91.41B58.05B72.41B-9.94B-105.04B
Net Income
144.07B317.02B230.06B376.00B44.24B
EBITDA
942.08B1215.30B1128.64B895.39B870.15B
 
Per Share Data
EPS Diluted Total Ops
46.03100.9472.91119.4514.12
Non GAAP EPS
46.03102.1873.61120.1214.20
 
Statistics
Gross Profit Margin
66.54%69.11%68.99%68.91%66.89%
Profit Margin
3.38%7.87%6.45%11.76%1.34%
Operating Profit Margin
5.02%13.68%15.28%10.50%8.71%

All data in JPY

Charts